High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort study

References

• Frank TD, Carter A, Jahagirdar D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV. 2019;6(12):e831–e859.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241–248. doi:https://doi.org/10.1016/s0140-6736(14)60604-8.
   PubMed Web of Science ®Google Scholar
• Smit M, Perez-Guzman PN, Mutai KK, et al. Mapping the current and future noncommunicable disease burden in Kenya by human immunodeficiency virus status: a modeling study. Clin Infect Dis. 2020;71(8):1864–1873. doi:https://doi.org/10.1093/cid/ciz1103.
   Web of Science ®Google Scholar
• Hsue PY, Waters DD. HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019;16(12):745–759. doi:https://doi.org/10.1038/s41569-019-0219-9.
   PubMed Web of Science ®Google Scholar
• Petoumenos K, Law MG. Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons. Curr Opin HIV AIDS. 2016;11(5):514–520. doi:https://doi.org/10.1097/coh.0000000000000306.
   PubMed Web of Science ®Google Scholar
• Ake JA, Polyak CS, Crowell TA, et al. Noninfectious comorbidity in the african cohort study. Clin Infect Dis. 2019;69(4):639–647. doi:https://doi.org/10.1093/cid/ciy981.
   Web of Science ®Google Scholar
• Castilho JL, Escuder MM, Veloso V, et al. Trends and predictors of non-communicable disease multimorbidity among adults living with HIV and receiving antiretroviral therapy in Brazil. J Int AIDS Soc. 2019;22(1):e25233. doi:https://doi.org/10.1002/jia2.25233.
   Web of Science ®Google Scholar
• Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS. 2016;30(10):1495–1509. doi:https://doi.org/10.1097/qad.0000000000001109.
   PubMed Web of Science ®Google Scholar
• Althoff KN, Gebo KA, Moore RD, et al. Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. Lancet HIV. 2019;6(2):e93–e104. doi:https://doi.org/10.1016/s2352-3018(18)30295-9.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhu H, Wu Y, et al. HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study. Lancet Infect Dis. 2014;14(11):1065–1072. doi:https://doi.org/10.1016/s1473-3099(14)70946-6.
   PubMed Web of Science ®Google Scholar
• Coorperative Meta-Analysis Group Of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Zhonghua Liu Xing Bing Xue Za Zhi. 2002;23(1):5–10. doi:https://doi.org/10.3760/j.issn:0254-6450.2002.01.003.
   Google Scholar
• Laaksonen MA, Virtala E, Knekt P, et al. SAS macros for calculation of population attributable fraction in a cohort study design. J Stat Softw. 2011;43(7):1–25. doi:https://doi.org/10.18637/jss.v043.i07.
   Web of Science ®Google Scholar
• Smit M, Brinkman K, Geerlings S, et al. Future challenges for clinical care of an ageing population infected with HIV: a modelling study. Lancet Infect Dis. 2015;15(7):810–818. doi:https://doi.org/10.1016/s1473-3099(15)00056-0.
   PubMed Web of Science ®Google Scholar
• Shah ASV, Stelzle D, Lee KK, et al. Global burden of atherosclerotic cardiovascular disease in people living With HIV: systematic review and meta-analysis. Circulation. 2018;138(11):1100–1112. doi:https://doi.org/10.1161/circulationaha.117.033369.
   PubMed Web of Science ®Google Scholar
• Driver JA, Djoussé L, Logroscino G, et al. Incidence of cardiovascular disease and cancer in advanced age: prospective cohort study. Br Med J. 2008;337:a2467. doi:https://doi.org/10.1136/bmj.a2467.
   PubMed Web of Science ®Google Scholar
• Helleberg M, Gerstoft J, Afzal S, et al. Risk of cancer among HIV-infected individuals compared to the background population: impact of smoking and HIV. AIDS. 2014;28(10):1499–1508. doi:https://doi.org/10.1097/QAD.0000000000000283.
   PubMed Web of Science ®Google Scholar
• Mdodo R, Frazier EL, Dube SR, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–344. doi:https://doi.org/10.7326/m14-0954.
   PubMed Web of Science ®Google Scholar
• Frazier EL, Sutton MY, Brooks JT, et al. Trends in cigarette smoking among adults with HIV compared with the general adult population, United States – 2009–2014. Prev Med. 2018;111:231–234. doi:https://doi.org/10.1016/j.ypmed.2018.03.007.
   PubMed Web of Science ®Google Scholar
• Mathabire Rücker SC, Tayea A, Bitilinyu-Bangoh J, et al. High rates of hypertension, diabetes, elevated low-density lipoprotein cholesterol, and cardiovascular disease risk factors in HIV-infected patients in Malawi. AIDS. 2018;32(2):253–260. doi:https://doi.org/10.1097/qad.0000000000001700.
   PubMed Web of Science ®Google Scholar
• Task Force on Chinese Guidelines for the Prevention of Cardiovascular Diseases (2017); Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the prevention of cardiovascular diseases(2017). Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46(1):10-25. doi:https://doi.org/10.3760/cma.j.issn.0253-3758.2018.01.004.
   Google Scholar
• Liu J, Sun L, Zhou Y, et al. Prevalence and characteristics of HBV infection among treatment-naive HIV-infected individuals in Shenzhen. Infect Dis Info. 2020;33(2):112–118. doi:https://doi.org/10.3969/j.issn.1007-8134.2020.02.004.
   Google Scholar
• Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403. doi:https://doi.org/10.1016/s2468-1253(18)30056-6.
   PubMed Web of Science ®Google Scholar
• Cao Y, Gong M, Han Y, et al. Prevalence and risk factors for chronic kidney disease among HIV-infected antiretroviral therapy-naïve patients in mainland China: a multicenter cross-sectional study. Nephrology (Carlton). 2013;18(4):307–312. doi:https://doi.org/10.1111/nep.12031.
   Web of Science ®Google Scholar
• Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373–384. doi:https://doi.org/10.1053/j.ajkd.2007.11.009.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Hou Y, et al. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study. Emerg Microbes Infect. 2020;9(1):2550–2561. doi:https://doi.org/10.1080/22221751.2020.1840928.
   PubMed Web of Science ®Google Scholar